No, from what I gather this is data on them using the exosome technology to assist in their ovarian cancer testing.
They hope to both use exosomes to increase the sensitivity of their serological tests and to sell exosomes to research groups and other companies that would benefit from the ability to extract specific markers from blood.
Again, I may be wrong, this is just my basic understanding. Read up on exosome technology (can find on their website) if you are interested.
Ann: BARD1 Collaborator Uni of QLD Announces Ovarian Cancer Data, page-14
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.0¢ |
Change
0.005(1.15%) |
Mkt cap ! $49.07M | |||
| Open | High | Low | Value | Volume |
| 43.5¢ | 44.0¢ | 43.0¢ | $12.55K | 28.78K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 33459 | 44.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 44.5¢ | 8500 | 1 |
View Market Depth
| Last trade - 15.55pm 15/11/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |